Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017

• Publication date: January 2013
• Report size: 239 pages

Small animal imaging is increasingly being implemented in the research studies from the late stage studies to the clinical phases. Imaging plays a significant role in the assessment of specific drug candidate or treatment regime, in phenotyping and understanding the pathophysiology of various diseases. Technologies used for in vivo small animal imaging allow longitudinal evaluation of disease as well as of drug therapy within the same animal, thu...

Small animal imaging is increasingly being implemented in the research studies from the late stage studies to the clinical phases. Imaging plays a significant role in the assessment of specific drug candidate or treatment regime, in phenotyping and understanding the pathophysiology of various diseases. Technologies used for in vivo small animal imaging allow longitudinal evaluation of disease as well as of drug therapy within the same animal, thus increasing efficacy and decreasing animal numbers used in research studies.

The overall small animal imaging (in vivo) market is valued at $790 million in 2012, and is estimated to grow at an annual growth rate of 14.5% over the next five years. The growing market shows preference towards new technologies such as hybrid systems – PET + SPECT + CT, SPECT + MRI and PET + MRI for the range of advantages offered by them over traditional standalone techniques. The global small animal imaging (in vivo) market has witnessed challenging and dynamic market conditions in terms of government funding/grants and technological advancements in the last five years. Small animal imaging (in vivo) industry has witnessed numerous technological advancements over the last two decades and it is expected to continue with the same trend in future to solve the present challenges and meet the demanding needs of the market.

The market growth is driven by factors such as increasing number of pharma companies and research institutions, rising application of functional imaging, growing adoption rate for small animal imaging and technological advancements. However, high device cost and technological limitations are the factors hindering the market growth. Sustainability of players in highly competitive environment, industry consolidation and availability of radiopharmaceuticals are the major challenges, while unique combinations in MRI high resolution and sensitivity of imaging devices with usage in multiple applications and emerging markets are the factors that seem to be favorable opportunities to the market.

In 2012, North America accounted for the biggest market share with about 38.2% share of the global small animal imaging (in vivo) systems and reagents market, followed by Europe. Though the Asian and Latin American countries signify to be the fastest growing markets due to growing number of research institutions and CRO’s, increasing government support for research and rising industry-academia partnerships for small animal research. The negative factors such as high competition in mature countries, economic slowdown and pricing pressures and will oblige the companies to focus on the Asian market.

Small animal imaging market seems to be highly competitive, as each player is focusing to gain a large market share. Rapid industry consolidation is a burning issue which is affecting the small market players and also forcing the major players to alter their marketing strategies.

This report includes company profiles of major players such as Bruker Corporation (U.S.), Siemens AG (Germany), Life Technologies Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Miltenyi Biotec GmbH (Germany), PerkinElmer, Inc. (U.S.), Bioscan, Inc. (U.S.), Mediso Medical Imaging Systems (Hungary), Gamma Medica (U.S.), Aspect Imaging (Israel), Targeson, Inc. (U.S.) and Scanco Medical (Switzerland).

Global Medical Imaging Industry

TABLE OF CONTENTS

1 INTRODUCTION 19

1.1 KEY TAKE-AWAYS 19
1.2 REPORT DESCRIPTION 19
1.3 MARKETS COVERED 20
1.4 STAKEHOLDERS 22
1.5 RESEARCH METHODOLOGY 22
1.5.1 MARKET SIZE 22
1.5.2 MARKET SHARE 23
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES 23
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES 23
1.5.5 ASSUMPTIONS 24

2 EXECUTIVE SUMMARY 25

3 MARKET OVERVIEW 31

3.1 INTRODUCTION 32
3.2 MARKET SEGMENTATION 35
3.2.1 SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY 35
3.2.2 SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENTS 38
3.3 MARKET DYNAMICS 39
3.3.1 DRIVERS 40
3.3.1.1 Technological Advancements 40
3.3.1.2 Growing Adoption Rate for small animal Imaging 41
3.3.1.3 Rising Application of Functional Imaging 41
3.3.1.4 Increasing Number of Pharma Companies and Research Institutions 42
3.3.2 RESTRAINTS 42
3.3.2.1 High Device Cost 42
3.3.2.2 Technological Limitations 43
3.3.2.3 High Cost and Data Requirements for Bringing New Technology 43
3.3.3 OPPORTUNITIES 44
3.3.3.1 Next Unique Combinations in MRI 44
3.3.3.2 High Resolution & Sensitivity of Imaging Devices with Usage in Multiple Applications 44
3.3.3.3 Emerging Markets 45
3.3.4 CHALLENGES 45
3.3.4.1 Sustainability of Players in Highly Competitive Market 45
3.3.4.2 Availability of Radiopharmaceuticals 46
3.4 MARKET SHARE ANALYSIS 47
3.4.1 BY TECHNOLOGY 47
3.4.2 BY MARKET PLAYERS 47
3.4.3 BY GEOGRAPHY 50

4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY 51

4.1 INTRODUCTION 52
4.2 STANDALONE TECHNOLOGY FOR SMALL ANIMAL IMAGING (IN VIVO) 54
4.2.1 NUCLEAR IMAGING 57
4.2.1.1 Micro-SPECT 59
4.2.1.2 Micro-PET 60
4.2.2 OPTICAL IMAGING 62
4.2.2.1 Fluorescence 65
4.2.2.2 Bioluminescence 66
4.2.2.3 Near Infrared Fluorescence 67
4.2.3 MICRO-MRI 69
4.2.4 MICRO-CT 71
4.2.5 MICRO-ULTRASOUND 73
4.3 MULTIMODAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO) 75
4.3.1 MULTIMODAL NUCLEAR IMAGING DEVICES 76
4.3.1.1 SPECT + CT 77
4.3.1.2 SPECT + MR 78
4.3.1.3 PET + CT 79
4.3.1.4 PET + MR 80
4.3.1.5 SPECT + PET + CT 81
4.3.2 MULTIMODAL OPTICAL IMAGING DEVICES 82
4.3.2.1 Optical+ X-ray + Radioisotopic 82

5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENTS 83

5.1 INTRODUCTION 84
5.2 NUCLEAR IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO) 86
5.2.1 PET TRACERS 88
5.2.1.1 Fluorine-18 based 92
5.2.1.2 Carbon-11 based 93
5.2.1.3 Copper-64 based 94
5.2.1.4 Others 95
5.2.2 SPECT PROBES 96
5.2.2.1 Technetium-99m based 97
5.2.2.2 Iodine-131 based 99
5.2.2.3 Gallium-67 based 100
5.2.2.4 Thallium-201 based 101
5.2.2.5 Others 102
5.3 OPTICAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO) 103
5.3.1 BIOLUMINESCENCE 104
5.3.1.1 Luciferins 106
5.3.1.2 Proluciferins 108
5.3.1.3 Coelenterazine 109
5.3.1.4 Others 110
5.3.2 FLUORESCENCE 111
5.3.2.1 Green Fluorescent Proteins 114
5.3.2.2 Red Fluorescent Proteins 115
5.3.2.3 Infrared Dyes 116
5.3.2.4 Others (Natural fluorescence Molecules such as Collagen and Elastin) 117
5.4 MRI CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO) 119
5.4.1 GADOLINIUM BASED 120
5.4.2 IRON BASED 121
5.5 CT CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO) 123
5.5.1 IODINE BASED 125
5.5.2 BARIUM BASED 126
5.5.3 GASTROGRAFIN BASED 127
5.6 ULTRASOUND CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO) 128
5.6.1 GADOLINIUM OXIDE ALBUMIN MICROSPHERES - GOAM 129

6 GEOGRAPHIC ANALYSIS 131

6.1 INTRODUCTION 132
6.2 NORTH AMERICA 133
6.3 EUROPE 139
6.4 ASIA-PACIFIC 144
6.5 REST OF THE WORLD (ROW) 151

7 COMPETITIVE LANDSCAPE 156

7.1 INTRODUCTION 156

8 COMPANY PROFILES 178

8.1 AGILENT TECHNOLOGIES, INC. 178
8.2 ASPECT IMAGING 183
8.3 BIOSCAN, INC. 187
8.4 BRUKER CORPORATION 192
8.5 FUJIFILM HOLDINGS CORPORATION 203
8.6 GAMMA MEDICA-IDEAS, INC. 209
8.7 GENOVIS AB 211
8.8 LI-COR BIOSCIENCES 216
8.9 LIFE TECHNOLOGIES CORPORATION 223
8.10 MEDISO MEDICAL IMAGING SYSTEMS 229
8.11 MILTENYI BIOTEC GMBH 232
8.12 PERKINELMER, INC. 236
8.13 PROMEGA CORPORATION 247
8.14 SCANCO MEDICAL AG 250
8.15 SIEMENS AG 253
8.16 SOFIE BIOSCIENCES, INC. 260
8.17 TARGESON, INC. 263
8.18 UVP, LLC. 267



LIST OF TABLES

TABLE 1 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE,
BY SEGMENTS, 2010 – 2017 ($MILLION) 26
TABLE 2 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 52
TABLE 3 SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 53
TABLE 4 GLOBAL SMALL ANIMAL STANDALONE SYSTEMS MARKET REVENUE,
BY TECHNOLOGY, 2010 – 2017 ($MILLION) 54
TABLE 5 SMALL ANIMAL STANDALONE SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 56
TABLE 6 GLOBAL SMALL ANIMAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 57
TABLE 7 SMALL ANIMAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 58
TABLE 8 SMALL ANIMAL MICRO-SPECT SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 60
TABLE 9 SMALL ANIMAL MICRO-PET SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 61
TABLE 10 GLOBAL SMALL ANIMAL OPTICAL IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 63
TABLE 11 SMALL ANIMAL OPTICAL IMAGING SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 64
TABLE 12 SMALL ANIMAL FLUORESCENCE SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 65
TABLE 13 SMALL ANIMAL BIOLUMINESCENCE SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 66
TABLE 14 SMALL ANIMAL NEAR INFRARED FLUORESCENCE SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 68
TABLE 15 SMALL ANIMAL MICRO-MRI SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 70
TABLE 16 SMALL ANIMAL MICRO-CT SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 72
TABLE 17 SMALL ANIMAL MICRO-ULTRASOUND SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 74
TABLE 18 SMALL ANIMAL MULTIMODAL NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 75
TABLE 19 SMALL ANIMAL MULTIMODAL NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 76
TABLE 20 SMALL ANIMAL SPECT/CT SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 77
TABLE 21 SMALL ANIMAL SPECT/MRI SYSTEMS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 78
TABLE 22 SMALL ANIMAL PET/CT SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 80
TABLE 23 SMALL ANIMAL PET/MRI SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 81
TABLE 24 GLOBAL SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION) 84
TABLE 25 SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 86
TABLE 26 GLOBAL SMALL ANIMAL NUCLEAR IMAGING RADIOTRACERS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 87
TABLE 27 SMALL ANIMAL NUCLEAR IMAGING RADIOTRACERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 87
TABLE 28 GLOBAL SMALL ANIMAL PET RADIOTRACERS MARKET REVENUE,
BY RADIOISOTOPES, 2010 – 2017 ($MILLION) 89
TABLE 29 SMALL ANIMAL PET RADIOTRACERS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 90
TABLE 30 EXAMPLES OF PET TRACERS USED IN ANIMAL IMAGING 91
TABLE 31 SMALL ANIMAL FLUORINE-18 BASED RADIOTRACERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 92
TABLE 32 SMALL ANIMAL CARBON-11 BASED RADIOTRACERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 93
TABLE 33 SMALL ANIMAL COPPER-64 BASED RADIOTRACERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 94
TABLE 34 SMALL ANIMAL OTHER PET RADIOTRACERS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 95
TABLE 35 GLOBAL SMALL ANIMAL SPECT PROBES MARKET REVENUE,
BY RADIOISOTOPES, 2010 – 2017 ($MILLION) 96
TABLE 36 SMALL ANIMAL SPECT PROBES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 97
TABLE 37 SMALL ANIMAL TECHNETIUM-99M BASED PROBES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 98
TABLE 38 SMALL ANIMAL IODINE-131 BASED PROBES MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 99
TABLE 39 SMALL ANIMAL GALLIUM-67 BASED PROBES MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 100
TABLE 40 SMALL ANIMAL THALLIUM-201 BASED PROBES MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 101
TABLE 41 SMALL ANIMAL OTHER SPECT PROBES MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 102
TABLE 42 GLOBAL SMALL ANIMAL OPTICAL IMAGING REAGENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION) 103
TABLE 43 SMALL ANIMAL OPTICAL IMAGING REAGENTS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 104
TABLE 44 GLOBAL SMALL ANIMAL BIOLUMINESCENT AGENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION) 105
TABLE 45 SMALL ANIMAL BIOLUMINESCENT AGENTS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 106
TABLE 46 SMALL ANIMAL LUCIFERINS IMAGING REAGENTS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 107
TABLE 47 SMALL ANIMAL PROLUCIFERINS IMAGING REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 109
TABLE 48 SMALL ANIMAL COELENTERAZINE IMAGING REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 110
TABLE 49 SMALL ANIMAL OTHER BIOLUMINESCENT IMAGING REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 111
TABLE 50 GLOBAL FLUORESCENT IMAGING REAGENTS MARKET REVENUE,
BY PRODUCTS, 2010 – 2017 ($MILLION) 112
TABLE 51 SMALL ANIMAL FLUORESCENT IMAGING REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 113
TABLE 52 SMALL ANIMAL GREEN FLUORESCENT PROTEINS IMAGING REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 114
TABLE 53 SMALL ANIMAL RED FLUORESCENT PROTEINS IMAGING REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 115
TABLE 54 SMALL ANIMAL INFRARED DYES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 117
TABLE 55 SMALL ANIMAL OTHER FLUORESCENT IMAGING AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 118
TABLE 56 GLOBAL SMALL ANIMAL MRI CONTRAST REAGENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION) 119
TABLE 57 SMALL ANIMAL MRI CONTRAST REAGENTS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 120
TABLE 58 SMALL ANIMAL GADOLINIUM-BASED MRI IMAGING AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 121
TABLE 59 SMALL ANIMAL IRON-BASED MRI IMAGING AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 122
TABLE 60 GLOBAL SMALL ANIMAL CT CONTRAST REAGENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION) 123
TABLE 61 SMALL ANIMAL CT CONTRAST REAGENTS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 124
TABLE 62 SMALL ANIMAL IODINE-BASED CT IMAGING AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 125
TABLE 63 SMALL ANIMAL BARIUM-BASED CT IMAGING AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 126
TABLE 64 SMALL ANIMAL GASTROGRAFIN-BASED CT IMAGING AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 127
TABLE 65 SMALL ANIMAL ULTRASOUND CONTRAST REAGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 129
TABLE 66 SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION) 132
TABLE 67 NORTH AMERICA: SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 134
TABLE 68 NORTH AMERICA: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 134
TABLE 69 NORTH AMERICA: SMALL ANIMAL STANDALONE IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 135
TABLE 70 NORTH AMERICA: SMALL ANIMAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY,
2010 – 2017 ($MILLION) 136
TABLE 71 NORTH AMERICA: SMALL ANIMAL OPTICAL IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 137
TABLE 72 NORTH AMERICA: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET REVENUE, 2010 – 2017 ($MILLION) 138
TABLE 73 EUROPE: SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE,
BY TECHNOLOGY, 2010 – 2017 ($MILLION) 140
TABLE 74 EUROPE: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 140
TABLE 75 EUROPE: SMALL ANIMAL STANDALONE IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 141
TABLE 76 EUROPE: SMALL ANIMAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 142
TABLE 77 EUROPE: SMALL ANIMAL OPTICAL IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 142
TABLE 78 EUROPE: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 143
TABLE 79 ASIA-PACIFIC: SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 145
TABLE 80 ASIA-PACIFIC: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 146
TABLE 81 ASIA-PACIFIC: SMALL ANIMAL STANDALONE IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 147
TABLE 82 ASIA-PACIFIC: SMALL ANIMAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY,
2010 – 2017 ($MILLION) 148
TABLE 83 ASIA-PACIFIC: SMALL ANIMAL OPTICAL IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 149
TABLE 84 ASIA-PACIFIC: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 150
TABLE 85 ROW: SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE,
BY TECHNOLOGY, 2010 – 2017 ($MILLION) 151
TABLE 86 ROW: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 152
TABLE 87 ROW: SMALL ANIMAL STANDALONE IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 153
TABLE 88 ROW: SMALL ANIMAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 154
TABLE 89 ROW: SMALL ANIMAL OPTICAL IMAGING SYSTEMS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 154
TABLE 90 ROW: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION) 155
TABLE 91 MERGERS & ACQUISITIONS, 2010 –2012 160
TABLE 92 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2010 – 2012 162
TABLE 93 NEW PRODUCT LAUNCH, 2009 – 2012 168
TABLE 94 EXPANSION, 2010 – 2012 176
TABLE 95 OTHER DEVELOPMENTS, 2009 –2012 177
TABLE 96 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION) 179
TABLE 97 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY SEGMENTS,
2009 – 2011 ($MILLION) 179
TABLE 98 AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION) 180
TABLE 99 BRUKER CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION) 193
TABLE 100 BRUKER CORPORATION: TOTAL REVENUE, BY SEGMENTS,
2009 – 2011 ($MILLION) 194
TABLE 101 BRUKER CORPORATION: TOTAL REVENUE, BY SEGMENTS,
2009 – 2011 ($MILLION) 195
TABLE 102 BRUKER CORPORATION: TOTAL REVENUE, BY SCIENTIFIC INSTRUMENTS SEGMENTS, 2009 – 2011 ($MILLION) 195
TABLE 103 BRUKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
2009 – 2011 ($MILLION) 196
TABLE 104 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2010 – 2012 ($MILLION) 204
TABLE 105 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION) 205
TABLE 106 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE,
BY GEOGRAPHY, 2010 – 2012 ($MILLION) 205
TABLE 107 GENOVIS AB: TOTAL REVENUE AND R&D EXPENSES,
2009 – 2011 ($THOUSAND) 212
TABLE 108 GENOVIS AB: TOTAL REVENUE, BY GEOGRAPHY,
2009 – 2011 ($THOUSAND) 212
TABLE 109 LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION) 224
TABLE 110 LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION) 224
TABLE 111 LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE,
BY GEOGRAPHY, 2009 – 2011 ($MILLION) 225
TABLE 112 PERKINELMER INC: TOTAL REVENUE AND R&D EXPENSES,
2009 – 2011 ($MILLION) 237
TABLE 113 PERKINELMER INC: TOTAL REVENUE, BY SEGMENTS,
2009 – 2011 ($MILLION) 237
TABLE 114 PERKINELMER, INC: TOTAL REVENUE, BY GEOGRAPHY,
2009 – 2011 ($MILLION) 238
TABLE 115 SIEMENS AG: TOTAL REVENUE AND R&D EXPENSES,
2009 – 2011 ($MILLION) 254
TABLE 116 SIEMENS AG: TOTAL REVENUE, BY SEGMENTS,
2009 – 2011 ($MILLION) 255
TABLE 117 SIEMENS AG: TOTAL REVENUE, BY GEOGRAPHY,
2009 – 2011 ($MILLION) 256



LIST OF FIGURES

FIGURE 1 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET,
BY TECHNOLOGY, 2012 VS 2017 27
FIGURE 2 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) REAGENTS MARKET,
BY TECHNOLOGY, 2012 VS 2017 28
FIGURE 3 SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY GEOGRAPHY, 2012 29
FIGURE 4 SMALL ANIMAL IMAGING (IN VIVO) TECHNOLOGIES MARKET SEGMENTATION 33
FIGURE 5 SMALL ANIMAL IMAGING (IN VIVO) MARKET SEGMENTATION 34
FIGURE 6 SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET SEGMENTATION 36
FIGURE 7 COMPARATIVE CHART ON SMALL ANIMAL IMAGING (IN VIVO) MODALITIES 37
FIGURE 8 SMALL ANIMAL IMAGING (IN VIVO) REAGENTS MARKET SEGMENTATION 38
FIGURE 9 MARKET DYNAMICS 39
FIGURE 10 GLOBAL SMALL ANIMAL IMAGING MARKET SHARE,
BY TECHNOLOGY, 2012 47
FIGURE 11 GLOBAL SMALL ANIMAL IMAGING MARKET SHARE,
BY KEY PLAYERS, 2012 48
FIGURE 12 GLOBAL SMALL ANIMAL NUCLEAR IMAGING MARKET SHARE,
BY KEY PLAYERS, 2012 49
FIGURE 13 GLOBAL SMALL ANIMAL OPTICAL IMAGING MARKET SHARE,
BY KEY PLAYERS, 2012 49
FIGURE 14 SMALL ANIMAL IMAGING SYSTEMS & REAGENTS MARKET SHARE,
BY GEOGRAPHY, 2012 VS. 2017 50
FIGURE 15 GLOBAL SMALL ANIMAL STANDALONE SYSTEMS MARKET REVENUE,
BY TECHNOLOGY, 2012 VS 2017 ($MILLION) 55
FIGURE 16 GLOBAL SMALL ANIMAL IMAGING REAGENTS & RADIOTRACERS SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION) 85
FIGURE 17 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET SHARE,
BY GROWTH STRATEGIES, 2010 – 2012 156
FIGURE 18 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCH STRATEGY,
2010 – 2012 157
FIGURE 19 KEY PLAYERS FOCUSING ON PARTNERSHIPS & COLLABORATIONS STRATEGY, 2010 – 2012 158
FIGURE 20 KEY PLAYERS FOCUSING ON MERGERS & ACQUISITIONS STRATEGY, 2010 – 2012 159